Two Sigma Advisers’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-259,320
| Closed | -$11.6M | – | 2186 |
|
|
2025
Q4 | $11.6M | Buy |
259,320
+241,220
| +1,333% | +$10.1M | 0.02% | 492 |
|
|
2025
Q3 | $727K | Sell |
18,100
-77,200
| -81% | -$2.72M | ﹤0.01% | 1610 |
|
|
2025
Q2 | $2.98M | Sell |
95,300
-203,500
| -68% | -$6.64M | 0.01% | 945 |
|
|
2025
Q1 | $10M | Buy |
298,800
+100
| +0% | +$3.8K | 0.02% | 530 |
|
|
2024
Q4 | $11.7M | Buy |
298,700
+25,000
| +9% | +$1.03M | 0.03% | 441 |
|
|
2024
Q3 | $10.8M | Buy |
273,700
+64,800
| +31% | +$2.61M | 0.03% | 470 |
|
|
2024
Q2 | $8.15M | Sell |
208,900
-20,300
| -9% | -$811K | 0.02% | 597 |
|
|
2024
Q1 | $9.87M | Sell |
229,200
-23,500
| -9% | -$1.08M | 0.02% | 542 |
|
|
2023
Q4 | $11.6M | Buy |
252,700
+187,800
| +289% | +$6.64M | 0.03% | 471 |
|
|
2023
Q3 | $2.22M | Buy |
+64,900
| New | +$2.43M | 0.01% | 1131 |
|
|
2023
Q1 | – | Sell |
-22,700
| Closed | -$895K | – | 2773 |
|
|
2022
Q4 | $895K | Sell |
22,700
-68,300
| -75% | -$2.49M | ﹤0.01% | 1622 |
|
|
2022
Q3 | $3.29M | Buy |
91,000
+38,700
| +74% | +$1.39M | 0.01% | 939 |
|
|
2022
Q2 | $1.59M | Sell |
52,300
-70,400
| -57% | -$2.13M | ﹤0.01% | 1328 |
|
|
2022
Q1 | $3.75M | Sell |
122,700
-3,900
| -3% | -$117K | 0.01% | 930 |
|
|
2021
Q4 | $3.96M | Sell |
126,600
-49,200
| -28% | -$1.47M | 0.01% | 875 |
|
|
2021
Q3 | $2.69M | Buy |
175,800
+92,800
| +112% | +$1.61M | 0.01% | 1090 |
|
|
2021
Q2 | $1.54M | Sell |
83,000
-5,900
| -7% | -$109K | ﹤0.01% | 1431 |
|
|
2021
Q1 | $1.59M | Sell |
88,900
-9,600
| -10% | -$163K | ﹤0.01% | 1387 |
|
|
2020
Q4 | $1.51M | Sell |
98,500
-7,200
| -7% | -$84.2K | ﹤0.01% | 1393 |
|
|
2020
Q3 | $1.17M | Buy |
105,700
+4,800
| +5% | +$56.5K | ﹤0.01% | 1434 |
|
|
2020
Q2 | $1.26M | Buy |
100,900
+37,400
| +59% | +$476K | ﹤0.01% | 1458 |
|
|
2020
Q1 | $720K | Buy |
63,500
+30,400
| +92% | +$433K | ﹤0.01% | 1641 |
|
|
2019
Q4 | $434K | Buy |
33,100
+6,200
| +23% | +$65.2K | ﹤0.01% | 1926 |
|
|
2019
Q3 | $242K | Sell |
26,900
-5,700
| -17% | -$53.9K | ﹤0.01% | 1992 |
|
|
2019
Q2 | $321K | Sell |
32,600
-4,500
| -12% | -$43.1K | ﹤0.01% | 1991 |
|
|
2019
Q1 | $377K | Buy |
37,100
+900
| +2% | +$7.63K | ﹤0.01% | 1905 |
|
|
2018
Q4 | $228K | Buy |
+36,200
| New | +$322K | ﹤0.01% | 2090 |
|
Other funds holding XENE
ACA
DCM
PCH
